Matches in Nanopublications for { ?s ?p ?o <http://purl.org/np/RA4wGuoHOd6g950TbjajO_ZppS80n9qBxwet5TThJXH-Y#assertion>. }
Showing items 1 to 19 of
19
with 100 items per page.
- DB00334 type Drug assertion.
- MONDO_0001156 type Disease assertion.
- context type Cohort assertion.
- association type ChemicalToDiseaseOrPhenotypicFeatureAssociation assertion.
- context label "Adults" assertion.
- MONDO_0001156 label "Borderline personality disorder (disease)" assertion.
- DB00334 label "Olanzapine" assertion.
- association label "The SGA olanzapine is considered the most appropriate, followed by quetiapine and aripiprazole. Although off-label prescription of SGAs represents a common clinical practice in accordance with a worldwide trend, the use of long-acting injection formulations was considered inappropriate by 69% of psychiatrists in our sample. Attitudes on off-label use of Olanzapine in the treatment of BPD: Highly inappropriate = 26 (12.9%); Innapropriate = 26 (12.9%); Doubt = 86 (42.5%); Appropriate = 64 (31.7%); Highly appropriate = 0 (0%)" assertion.
- association subject DB00334 assertion.
- association predicate treats assertion.
- association object MONDO_0001156 assertion.
- association has_population_context context assertion.
- association relation NCIT_C94303 assertion.
- context category Cohort assertion.
- DB00334 category Drug assertion.
- MONDO_0001156 category Disease assertion.
- association category ChemicalToDiseaseOrPhenotypicFeatureAssociation assertion.
- association publications 31609189 assertion.
- association aggregator_knowledge_source knowledge-collaboratory assertion.